Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Mayo Clinic Proceedings|January 12, 2000
Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complicationsR S Go, T G CallLeukemia & Lymphoma|June 1, 1994
Effects of phenylacetate on cells from patients with B-chronic lymphocytic leukemiaT G Call, M J Stenson, T E WitzigBlood Cancer Journal|August 6, 2016
A population-based study of large granular lymphocyte leukemiaM V Shah, C C Hook, T G Call, et al.The American Journal of Tropical Medicine and Hygiene|January 1, 1988
Ocular angiostrongyliasis in Japan: a case reportR G Nelson, R C Warren, F A Scotti, et al.Mayo Clinic Proceedings|April 1, 1994
Incidence of leukemia in Olmsted County, Minnesota, 1975 through 1989T G Call, P Noël, T M Habermann, et al.Mayo Clinic Proceedings|April 1, 1994
Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosisT G Call, R L Phyliky, P Noël, et al.Leukemia Research|December 6, 2005
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignanciesT D Shanafelt, Y K Lee, T G Call, et al.American Journal of Clinical Oncology|August 1, 1994
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant diseaseT G Call, E T Creagan, S Frytak, et al.Leukemia|August 28, 2015
Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosisB M Solomon, K G Chaffee, J Moreira, et al.British Journal of Haematology|July 27, 2001
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasiaR A Mesa, A Tefferi, M A Elliott, et al.Pageof 2